PREVENT partners
Funding partners | R & D partners
Funding partners
Pan-Provincial Vaccine Enterprise (PREVENT) is a $25.5 million national vaccine commercialization consortium.
Federal funding ($15 million) is from the Networks of Centres of Excellence (NCE) through its Centres of Excellence for Commercialization and Research program (CECR).
$10.5 million of in-kind support comes from PREVENT's three partners – VIDO/InterVac in Saskatoon, the BC Centre for Disease Control in Vancouver, and the Canadian Center for Vaccinology (a partnership among Dalhousie University, the IWK Health Centre and Capital Health) in Halifax.
Federal Networks of Centres of Excellence (NCE)
The federal Networks of Centres of Excellence (NCE) programs fund partnerships between universities, industry, government and not-for-profit organizations. They help turn Canadian research and entrepreneurial talent into economic and social benefits for all Canadians.
The NCE mandate aligns naturally with the federal S&T Strategy, launched in May 2007, which promotes a People, a Knowledge and an Entrepreneurial Advantage for Canada.
The Pan-Provincial Vaccine Enterprise (PREVENT) is funded by the CECR program, to further its goal of creating world-class centres to advance research and facilitate commercialization of technologies, products and services.
The four Networks of Centres of Excellence programs are:
Networks of Centres of Excellence (NCE)
Centres of Excellence for Commercialization and Research (CECRs)
Business-Led Networks of Centres of Excellence (BL-NCEs)
Industrial Research and Development Internship program (IRDI)

